Healthstream (HSTM) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $27.00 from $24.00 | Jul 21, 2026 |
| Canaccord Genuity | Maintained | Hold | $24.00 from $21.00 | May 6, 2026 |
| Canaccord Genuity | Maintained | Hold | $28.00 | Dec 17, 2025 |
| Canaccord Genuity | Maintained | Hold | $28.00 from $29.00 | Aug 7, 2025 |
| Canaccord Genuity | Maintained | Hold | $29.00 from $30.00 | May 15, 2025 |
| Canaccord Genuity | Maintained | Hold | $30.00 from $29.00 | Feb 26, 2025 |
| JMP Securities | Maintained | Market Perform | — | Feb 6, 2025 |
| Canaccord Genuity | Maintained | Hold | $29.00 from $28.00 | Oct 23, 2024 |
| Barclays | Maintained | Overweight | $34.00 from $32.00 | Oct 23, 2024 |
| Canaccord Genuity | Maintained | Hold | $28.00 from $27.00 | Jul 24, 2024 |
| JMP Securities | Initiated Coverage | Market Perform | — | Dec 6, 2023 |
Frequently asked questions
Is HSTM a buy, sell, or hold?
Analysts covering Healthstream currently average a Hold rating: 2 buy, 3 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on HSTM?
On Jul 21, 2026, Canaccord Genuity maintained Healthstream at Hold with a price target of $27.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.